An inhibitor of PI3KαH1047R
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

RLY-2608

Item No. 44472

Technical Information
Formal Name
N-[(3R)-3-(2-chloro-5-fluorophenyl)-6-(5-cyano[1,2,4] triazolo[1,5-a]pyridin-6-yl)-2,3-dihydro-1-oxo-1H-isoindol-4-yl]-3-fluoro-5-(trifluoromethyl)-benzamide
CAS Number
2733573-94-7
Molecular Formula
C29H14ClF5N6O2
Formula Weight
Purity
≥95%
A solid
DMSO: Soluble: ≥10 mg/ml
SMILES
FC1=CC([C@@H]2NC(C3=CC(C4=C(C#N)N5N=CN=C5C=C4)=CC(NC(C6=CC(C(F)(F)F)=CC(F)=C6)=O)=C32)=O)=C(Cl)C=C1
InChi Code
InChI=1S/C29H14ClF5N6O2/c30-21-3-1-16(31)10-19(21)26-25-20(28(43)40-26)7-13(18-2-4-24-37-12-38-41(24)23(18)11-36)8-22(25)39-27(42)14-5-15(29(33,34)35)9-17(32)6-14/h1-10,12,26H,(H,39,42)(H,40,43)/t26-/m0/s1
InChi Key
VYWRYBZVVSPTQN-SANMLTNESA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Kinase Resource Center
    Discover Products & Resources for Kinase Research
    • Kinase inhibitors, screening libraries, assay kits, & more
    • Tools to study kinase signaling pathways:
      • Growth factor signaling
      • PI3K/Akt/mTOR
      • MAPKs (ERK, p38, & JNK)
      • JAK/STAT signaling
    • Articles, resources, & advice
    EXPLORE NOW
    Product Description

    RLY-2608 is an inhibitor of PI3Kα containing a histidine-to-arginine mutation at position 1,047 (PI3KαH1047R; IC50 = 4 nM).1 It is selective for PI3KαH1047R over wild-type PI3Kα (IC50 = 48 nM). RLY-2608 (25 and 100 mg/kg) reduces tumor volume in T47D and ST1056 PI3KαH1047R mutant-containing breast cancer mouse xenograft models.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Varkaris, A., Pazolli, E., Gunaydin, H., et alDiscovery and clinical proof-of-concept of RLY-2608, a first-in-class mutant-selective allosteric PI3Kα inhibitor that decouples antitumor activity from hyperinsulinemia. Cancer Discov. 14(2), 240-257 (2024).